Table 2 Distribution of antimalarial drugs and co-medication prescribed by facility
Antimalarial drugs | Total facility n (%) | NAUMC Awka n (%) | NAUTH Nnewi n (%) | Chi square difference | P = value |
|---|---|---|---|---|---|
Artemisinin-based combinations (ACTs) | 2027 (93) | 1198 (95) | 829 (91) | 13.02 | 0.0003*** |
Artemether-lumefantrin | 1024 (50.5) | 647 (54) | 377 (45.5) | - | - |
Artesunate-amodiaquine | 244 (12) | 206 (17.2) | 38 (4.5) | - | - |
Artesunate-mefloquine | 232 (11.5) | - | 232 (28) | - | - |
Artesunate-pyridoxine + pyrimethamine | 188 (9.3) | 56 (4.7) | 132 (16) | - | - |
Dihydroartemisinin-piperaquine | 339 (16.7) | 289 (24.1) | 50 (6) | - | - |
Mono-therapy | 144 (7) | 63 (5) | 81 (9) | 13.02 | 0.0003*** |
Artesunate | 42 (29.2) | 7 (11.1) | 35 (43.2) | - | - |
Amodiaquine | 14 (9.7) | - | 14 (17.3) | - | - |
Proguanil | 15 (10.4) | 1 (1.6) | 14 (17.3) | - | - |
Quinine | 6 (4.2) | 6 (9.5) | - | - | - |
Sulphadoxine + pyrimethamine | 67 (46.5) | 49 (77.8) | 18 (22.2) | - | - |
Proportion of co-medication n (%) | 1722 (97) | 1248 (99) | 864 (95) | 32.37 | 0.0001*** |
Analgesics | 1722 (79) | 1124 (89) | 598 (66) | 176.8 | 0.0001*** |
Vitamin preparations | 1364 (63) | 993 (79) | 371 (41) | 324.8 | 0.0001*** |
Antibiotics | 1084 (50) | 721 (57) | 363 (40) | 63.18 | 0.0001*** |